Elevated soluble interleukin 2 receptors are associated with inflammatory arthritis but are not helpful in making a specific diagnosis
Hakala, M.; Karttunen, R.; Ilonen, J.
Journal of Rheumatology 20(8): 1448-1449
1993
ISSN/ISBN: 0315-162X PMID: 8230044 Document Number: 419656
Document emailed within 1 workday
Related Documents
Coaccioli, S.; Pinoca, F.; Giuliani, M.; Landucci, P.; Sabatini, C.; Puxeddu, A. 2007: Definition of adult-onset rheumatoid arthritis from elderly-onset rheumatoid arthritis by studying T-lymphocyte subpopulations, their soluble receptors and soluble receptor of interleukin-2 La Clinica Terapeutica 158(4): 303-306Wolf, R.E.; Brelsford, W.G.; Hall, V.C.; Adams, S.B. 1992: Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis Journal of Rheumatology 19(4): 524-528
Medvedev, A.N.; Korshunov, N.I.; Nasonov, E.L.; Baranov, A.A.; Shilkina, B.N. 1997: The effect of cyclosporin a (Sandimmun) on the level of soluble interleukin-2 receptors in rheumatoid arthritis Terapevticheskii Arkhiv 69(8): 19-21
Reddy, M.M.; Weissman, A.M.; Mazza, D.S.; Meriney, D.K.; Johns, M.; Carrabis, S.; Grieco, M.H. 1992: Circulating elevated levels of soluble CD23, interleukin-4, and CD20+CD23+ lymphocytes in atopic subjects with elevated serum IgE concentrations Annals of Allergy 69(2): 131-134
Harrington, D.S.; Patil, K.; Lai, P.K.; Yasuda, N.N.; Armitage, J.O.; Ip, S.H.; Weisenburger, D.D.; Linder, J.; Purtilo, D.T. 1988: Soluble interleukin 2 receptors in patients with malignant lymphoma Archives of Pathology and Laboratory Medicine 112(6): 597-601
Siegert, W.; Josimovic-Alasevic, O.; Schwerdtfeger, R.; Baurmann, H.; Schmidt, C.A.; Musch, R.; Schmid, H.J.; Hartmann, R.; Henze, G.; Huhn, D. 1990: Soluble interleukin 2 receptors in patients after bone marrow transplantation Bone Marrow Transplantation 6(2): 97-101
Semenzato, G.; Cipriani, A.; Trentin, L.; Zambello, R.; Masciarelli, M.; Vinante, F.; Chilosi, M.; Pizzolo, G. 1987: High serum levels of soluble interleukin-2 receptors in sarcoidosis Sarcoidosis 4(1): 25-27
Sugimoto, H.; Hashimoto, N.; Suzuki, S.; Gejyo, F. 1996: The clinical significance of the measurement of serum soluble interleukin-2 receptors in various diseases Rinsho Byori. Japanese Journal of Clinical Pathology 44(2): 176-182
Virstiuk, N.H. 2004: Diagnostic value of soluble interleukin-2 receptors in patients with alcoholic liver disease Likars'ka Sprava 2004(3-4): 39-42
Salvarani, C.; Macchioni, P.; Boiardi, L.; Rossi, F.; Casadei Maldini, M.; Mancini, R.; Beltrandi, E.; Spacca, C.; Lodi, L.; Portioli, I. 1992: Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations Journal of Rheumatology 19(7): 1100-1106
Arend, W.P.; Malyak, M.; Smith, M.F.; Whisenand, T.D.; Slack, J.L.; Sims, J.E.; Giri, J.G.; Dower, S.K. 1994: Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids Journal of Immunology 153(10): 4766-4774
Totanarungroj, K.; Watcharaporn, C.; Muangman, N. 2010: Helpful CT findings for giving specific diagnosis of anterior mediastinal tumors Journal of the Medical Association of Thailand 93(4): 489-496
Duclos, B.; Reimund, J.M.; Lang, J.M.; Coumaros, G.; Chamouard, P.; Lehr, L.; Baumann, R.; Koehl, C.; Weill, J.P. 1990: Mononuclear cell activation in Crohn's disease. Evaluation using serum assay of neopterin and interleukin-2 soluble receptors Gastroenterologie Clinique et Biologique 14(1): 22-27
Lissoni, P.; Barni, S.; Tancini, G.; Viviani, S.; Rovelli, F.; Rescaldani, R.; Fiorelli, G. 1989: Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms Journal of Biological Regulators and Homeostatic Agents 3(3): 131-133
Boiardi, L.; Macchioni, P.; Salvarani, C.; Rossi, F.; Casadei-Maldini, M.; Mancini, R.; Beltrandi, E.; Portioli, I. 1994: Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment Clinical and Experimental Rheumatology 12(4): 357-362
Boznański, A.; Willak-Janc, E.; Domanasiewicz, M.; Pirogowicz, I.; Widerska, A. 1996: Evaluation of soluble components of receptors with weak affinity for IgE (sCD23) in children with pollinosis given specific immunotherapy Pneumonologia i Alergologia Polska 64(7-8): 386-391
Kuuliala, A.; Leirisalo-Repo, M.; Möttönen, T.; Hannonen, P.; Nissilä, M.; Kautiainen, H.; Korpela, M.; Julkunen, H.; Hakola, M.; Repo, H. 2005: Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug Clinical and Experimental Rheumatology 23(2): 243-246
Jin Sheng, Y.; Florentin, I.; Bird, J.; Esnous, D.; Pompidou, A.; Giroud, J.P. 1982: The enhancement of interleukin 2 like production after in vivo stimulation of rat lymphoid cells by an acute non specific inflammatory process Biomedicine and PharmacoTherapy 36(10): 436-440
Maekawa, H.; Ishiyama, N.; Furuya, N.; Nakahara, K.; Saito, S.; Uchimura, H. 1997: Serum soluble CD8 and soluble interleukin-2-receptor levels during interferon therapy in chronic hepatitis C Rinsho Byori. Japanese Journal of Clinical Pathology 45(10): 1003-1007
Ninomiya, Y.; Obara, A.; Sugawara, K.; Konishi, K. 1991: A study on interleukin 2 and soluble interleukin 2 receptor in serum and bronchoalveolar lavage fluid from patients with farmer's lung Nihon Kyobu Shikkan Gakkai Zasshi 29(11): 1399-1406